Showing 1,221 - 1,240 results of 2,072 for search '(( significant decrease decrease ) OR ( significant progress decrease ))~', query time: 0.34s Refine Results
  1. 1221

    Image 3_Profiling of fecal analytes as a potential biomarker in rheumatoid arthritis.tif by Zhiyi Wang (328693)

    Published 2025
    “…Fecal zonulin and plasma HIF-2α were significantly elevated in both NA and D2T groups, whereas fecal D-lactate showed a pronounced decrease in the NA and D2T groups. …”
  2. 1222

    Image3_DNA methylation-mediated FGFR1 silencing enhances NF-κB signaling: implications for asthma pathogenesis.TIF by Minglu Meng (19725085)

    Published 2024
    “…Overexpression of FGFR1 in BEAS-2B cells significantly enhanced cell proliferation and stimulated NF-ĸB transcriptional activity in HERK-293T cells. …”
  3. 1223

    Table 1_Efficacy of Yang Yin Sheng Xue formula against canine lymphoma chemotherapy-induced myelosuppression.docx by Wanbing Pan (22035863)

    Published 2025
    “…In the clinical phase, a decrease in complete blood count (CBC) indicators was observed after the eighth chemotherapy cycle in multicentric lymphoma canines, significantly delaying the onset of chemotherapy-induced reductions (p < 0.05) compared to the Control Group (third chemotherapy cycle).…”
  4. 1224

    Image 4_Profiling of fecal analytes as a potential biomarker in rheumatoid arthritis.tif by Zhiyi Wang (328693)

    Published 2025
    “…Fecal zonulin and plasma HIF-2α were significantly elevated in both NA and D2T groups, whereas fecal D-lactate showed a pronounced decrease in the NA and D2T groups. …”
  5. 1225

    Image2_DNA methylation-mediated FGFR1 silencing enhances NF-κB signaling: implications for asthma pathogenesis.TIF by Minglu Meng (19725085)

    Published 2024
    “…Overexpression of FGFR1 in BEAS-2B cells significantly enhanced cell proliferation and stimulated NF-ĸB transcriptional activity in HERK-293T cells. …”
  6. 1226

    Image 1_Profiling of fecal analytes as a potential biomarker in rheumatoid arthritis.tif by Zhiyi Wang (328693)

    Published 2025
    “…Fecal zonulin and plasma HIF-2α were significantly elevated in both NA and D2T groups, whereas fecal D-lactate showed a pronounced decrease in the NA and D2T groups. …”
  7. 1227

    Image1_DNA methylation-mediated FGFR1 silencing enhances NF-κB signaling: implications for asthma pathogenesis.TIF by Minglu Meng (19725085)

    Published 2024
    “…Overexpression of FGFR1 in BEAS-2B cells significantly enhanced cell proliferation and stimulated NF-ĸB transcriptional activity in HERK-293T cells. …”
  8. 1228

    Data_Sheet_1_Investigating the impact of mental rehearsal on prefrontal and motor cortical haemodynamic responses in surgeons using optical neuroimaging.docx by Hemel N. Modi (19919895)

    Published 2024
    “…Technical performance was measured using leak volume, objective performance score and task progression score.</p>Results<p>MR led to a decrease in HbO<sub>2</sub> (reduced activation) in the bilateral prefrontal cortex (PFC), and an increase in HbO<sub>2</sub> (increased activation) in the left middle frontal gyrus, left precentral gyrus, and left postcentral gyrus. …”
  9. 1229

    Table 1_HIF1A acts as target of XiHuang Pill in the treatment of papillary thyroid cancer by regulating dedifferentiation.xlsx by Xu-Zhe Yu (21509801)

    Published 2025
    “…HIF1A inhibited differentiation of PTC cells, while XHP suppressed PTC progression and promoted differentiation by downregulating HIF1A. …”
  10. 1230

    Image 1_HIF1A acts as target of XiHuang Pill in the treatment of papillary thyroid cancer by regulating dedifferentiation.tif by Xu-Zhe Yu (21509801)

    Published 2025
    “…HIF1A inhibited differentiation of PTC cells, while XHP suppressed PTC progression and promoted differentiation by downregulating HIF1A. …”
  11. 1231

    Data Sheet 1_SLC4A10 impedes atherosclerosis by diminishing IFN-γ/GZMB levels of CD8+ T cells via the MAPK pathway.zip by Bo Chen (32294)

    Published 2025
    “…</p>Conclusions<p>These data demonstrate that SLC4A10 mitigates cytotoxicity by decreasing the levels of IFN-γ/GZMB of SLC4A10<sup>+</sup> CD8<sup>+</sup> T cells via the MAPK pathway, which impedes plaque progression and aids stabilization.…”
  12. 1232

    Table 2_SLC4A10 impedes atherosclerosis by diminishing IFN-γ/GZMB levels of CD8+ T cells via the MAPK pathway.docx by Bo Chen (32294)

    Published 2025
    “…</p>Conclusions<p>These data demonstrate that SLC4A10 mitigates cytotoxicity by decreasing the levels of IFN-γ/GZMB of SLC4A10<sup>+</sup> CD8<sup>+</sup> T cells via the MAPK pathway, which impedes plaque progression and aids stabilization.…”
  13. 1233

    Data Sheet 1_Combined effect of esaxerenone and dapagliflozin on aldosterone-mediated sodium reabsorption and potassium excretion.docx by Motonobu Nakamura (5944421)

    Published 2025
    “…TWIK-1 expression did not significantly decrease in rats continuously treated with ESX and Dapa compared with that in rats treated with ESX alone.…”
  14. 1234

    Image 1_SLC4A10 impedes atherosclerosis by diminishing IFN-γ/GZMB levels of CD8+ T cells via the MAPK pathway.pdf by Bo Chen (32294)

    Published 2025
    “…</p>Conclusions<p>These data demonstrate that SLC4A10 mitigates cytotoxicity by decreasing the levels of IFN-γ/GZMB of SLC4A10<sup>+</sup> CD8<sup>+</sup> T cells via the MAPK pathway, which impedes plaque progression and aids stabilization.…”
  15. 1235

    DataSheet1_Characteristics of adverse reactions of three anti-glioma drugs in WHO-VigiAccess.ZIP by Huadong Ke (19937268)

    Published 2024
    “…The analysis revealed that the ten most frequently reported AEs included bone marrow suppression, myalgia, leukopenia, thrombocytopenia, nausea, vomiting, death, rhabdomyolysis, disease progression, and a decrease in neutrophil count. The five most common categories of AEs related to anti-glioma drugs were blood and lymphatic system diseases (20,233 cases, 15.2%), general disorders and administration site conditions (26,973 cases, 20.3%), gastrointestinal dysfunction (22,061 cases, 16.7%), necessitating further investigations (18,285 cases, 13.8%), and musculoskeletal and connective tissue diseases (30,695 cases, 23.1%). …”
  16. 1236

    Table 1_SLC4A10 impedes atherosclerosis by diminishing IFN-γ/GZMB levels of CD8+ T cells via the MAPK pathway.docx by Bo Chen (32294)

    Published 2025
    “…</p>Conclusions<p>These data demonstrate that SLC4A10 mitigates cytotoxicity by decreasing the levels of IFN-γ/GZMB of SLC4A10<sup>+</sup> CD8<sup>+</sup> T cells via the MAPK pathway, which impedes plaque progression and aids stabilization.…”
  17. 1237

    Data Sheet 1_Promoting the development and approval of new traditional Chinese medicines in China: a pooled analysis of data from 2013 to 2024.docx by Xiaohong Long (20871797)

    Published 2025
    “…Although the review time for TCMs has significantly decreased after the reform, the overall development time has increased. …”
  18. 1238

    Data_Sheet_1_Analysis of spatial and temporal characteristics and evolution of green total factor productivity in agriculture in the lower Yellow River basin.xlsx by Junru He (20158257)

    Published 2024
    “…The results demonstrate that agricultural carbon emissions in the Lower Yellow River Basin gradually decreased throughout the study period. Furthermore, overall carbon emission efficiency improved, indicating significant potential for further emission reduction. …”
  19. 1239

    Table 2_Epidemiological trends and future projections of ischemic stroke in children and adolescents: a global analysis from 1990 to 2021.docx by Yi Liu (36759)

    Published 2025
    “…By 2036, incidence and prevalence may rise, particularly in the 15–19 age group, although mortality and DALYs are expected to continue decreasing.</p>Conclusion<p>Ischemic stroke in this group shows an “increasing case number but decreasing mortality” trend, highlighting medical progress but ongoing risks. …”
  20. 1240

    Table 1_Epidemiological trends and future projections of ischemic stroke in children and adolescents: a global analysis from 1990 to 2021.docx by Yi Liu (36759)

    Published 2025
    “…By 2036, incidence and prevalence may rise, particularly in the 15–19 age group, although mortality and DALYs are expected to continue decreasing.</p>Conclusion<p>Ischemic stroke in this group shows an “increasing case number but decreasing mortality” trend, highlighting medical progress but ongoing risks. …”